BamSEC and AlphaSense Join Forces
Learn More

Tribute Pharmaceuticals Canada Inc.

Plans of Reorganization, Merger, Acquisition or Similar Filter

EX-2.2
from 8-K 25 pages Amendment No. 2 to Agreement and Plan of Merger and Arrangement
12/34/56
EX-2.1
from 8-K 5 pages Amendment No. 1 to Agreement and Plan of Merger and Arrangement
12/34/56
EX-2.1
from 8-K 89 pages Agreement and Plan of Merger and Arrangement Among Tribute Pharmaceuticals Canada Inc., Aguono Limited, Trafwell Limited, Arlz US Acquisition Corp., Arlz Ca Acquisition Corp., and Pozen Inc. June 8, 2015
12/34/56
EX-2.2
from 8-K/A 13 pages License Agreement
12/34/56
EX-2.1
from 8-K/A 25 pages Asset Purchase Agreement Between Novartis Pharma AG Novartis AG and Tribute Pharmaceuticals Canada Inc. 1
12/34/56
EX-2.2
from 8-K 10 pages License Agreement
12/34/56
EX-2.1
from 8-K 24 pages Asset Purchase Agreement
12/34/56
EX-2.1
from 8-K/A 61 pages Share Purchase Agreement Between Stellar Pharmaceuticals Inc. and Elora Financial Management Inc. and Mary-Ann Harris and Rob Harris and Scott Langille 1
12/34/56
EX-2
from 10QSB 13 pages Stellar Pharmaceuticals Inc. Condensed Interim Financial Statements (Canadian Funds) (Unaudited) March 31, 2006 Stellar Pharmaceuticals Inc. March 31, 2006 Contents
12/34/56
EX-2
from 10QSB 14 pages Stellar Pharmaceuticals Inc. Interim Financial Statements (Canadian Funds) (Unaudited) September 30, 2005 Stellar Pharmaceuticals Inc. September 30, 2005 Contents
12/34/56
EX-2
from 10QSB 12 pages Stellar Pharmaceuticals Inc. Interim Financial Statements (Canadian Funds) (Unaudited) June 30, 2005 Stellar Pharmaceuticals Inc. June 30, 2005 Contents
12/34/56
EX-2
from 10QSB 2 pages Certification Pursuant to Rule 13a-14
12/34/56
EX-2
from 10QSB 11 pages Stellar International Inc. Interim Financial Statements (Unaudited - Prepared by Management) March 31, 2004 Stellar International Inc. March 31, 2004 Contents
12/34/56
EX-2
from 10KSB 1 page Via Electronic Transmission April 7, 2004 Dear Sir or Madam: Re: Stellar International Inc. We Are Pleased to Confirm That Copies of the Following Materials Were Mailed to Shareholders on April 6, 2004. Equity Transfer Services Inc. Per
12/34/56
EX-2
from 10QSB 1 page Results of Operations for 3 Months Ending September 30, 2003 - - USA Overview the Quarterly Results for 2003 Had Revenue Growth 20.9 % Ahead of the Same Quarter in 2002 and a September 2003 Year-To-Date Sales Growth Up 29.7 % Over the Same Period in 2002. Historically the Third Quarter Ending September 30 Is a Low Productivity Quarter Due to the Summer Months
12/34/56